Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05333367 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

Study acronym: MORPHEE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 21, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Jul 2023 to Jul 2025v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2022 to Apr 15, 2022
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to describe the type of cell death induced by extracorporeal photochemotherapy, depending on the cell type, using a panel of complementary analysis techniques.
Trial Details
NCT Number NCT05333367
Lead Sponsor Centre Hospitalier Universitaire de Besancon
Conditions
(from sponsor)		 Cutaneous T-Cell Lymphoma, Graft Vs Host Disease, Graft Rejection
Related terms Graft vs Host Disease, Lymphoma, T-Cell, Cutaneous
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov